News
Here are six new shortages and discontinuations for April, according to drug supply databases from the FDA and the American ...
If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...
The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...
A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...
4d
MarketBeat on MSNHims’ Weight Loss Expansion: Real Growth or Just Hype?Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s, which have exploded in ...
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli ...
The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.
They took metformin and 1.8 milligrams of liraglutide for at least four weeks and experienced an average weight loss of about 20 pounds. Finally, a 2021 study funded by Novo Nordisk (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results